These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 2968448
1. Evaluation of the pharmacologic properties of a vasopressin antagonist in Brattleboro rats. Mah SC, Hofbauer KG. J Pharmacol Exp Ther; 1988 Jun; 245(3):1028-32. PubMed ID: 2968448 [Abstract] [Full Text] [Related]
2. Biologic response to chronic blockade of vasopressin receptors in Sprague-Dawley rats. Mah SC, Opperman JR, Baum HP, Hofbauer KG. J Pharmacol Exp Ther; 1988 Jun; 245(3):1021-7. PubMed ID: 2968447 [Abstract] [Full Text] [Related]
6. Effect of the vasopressin antagonist d/CH2/5Tyr/Et/VAVP on the antidiuretic action of exogenous and endogenous vasopressin. László FA, Csáti S, Baláspiri L. Acta Endocrinol (Copenh); 1984 May; 106(1):52-5. PubMed ID: 6730854 [Abstract] [Full Text] [Related]
9. Effects of angiotensin and vasopressin V(1) receptors on water and sodium intake induced by injection of vasopressin into lateral septal area. Mima EG, Andrade RR, Camargo LA, Saad WA. Regul Pept; 2004 May 15; 118(3):159-64. PubMed ID: 15003832 [Abstract] [Full Text] [Related]
11. Up-regulation of renal adenylate cyclase-coupled vasopressin receptors after chronic administration of vasopressin antagonists to rats. Caltabiano S, Kinter LB. J Pharmacol Exp Ther; 1991 Sep 15; 258(3):1046-54. PubMed ID: 1832462 [Abstract] [Full Text] [Related]
12. Pharmacological evaluation of d(CH2)5Tyr(Me)AVP as an antagonist of vasopressin-induced contraction of the isolated rat caudal artery. Clineschmidt BV, Lis EV. Arch Int Pharmacodyn Ther; 1986 Nov 15; 284(1):72-84. PubMed ID: 2950833 [Abstract] [Full Text] [Related]
13. Effect of vasopressin antagonist d(CH2)5Tyr(Et)VAVP on plasma arginine vasopressin level after osmotic stimulus. László FA, Laczi F, Janáky T, Baláspiri L. Endocr Regul; 1991 Sep 15; 25(3):181-3. PubMed ID: 1764609 [Abstract] [Full Text] [Related]
14. A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926. Stassen FL, Heckman G, Schmidt D, Nambi P, Aiyar N, Landvatter S, Crooke ST. Mol Pharmacol; 1987 Mar 15; 31(3):267-72. PubMed ID: 2951585 [Abstract] [Full Text] [Related]
15. Antidiuretic effects of a nonpeptide vasopressin V(2)-receptor agonist, OPC-51803, administered orally to rats. Nakamura S, Hirano T, Tsujimae K, Aoyama M, Kondo K, Yamamura Y, Mori T, Tominaga M. J Pharmacol Exp Ther; 2000 Dec 15; 295(3):1005-11. PubMed ID: 11082435 [Abstract] [Full Text] [Related]
17. Effect of the vasopressin antagonist d(CH2)5 Tyr(Et)VAVP on diuresis in rat. László FA, Csáti S, Baláspiri L, Manning M. Acta Med Hung; 1984 Dec 15; 41(1):65-73. PubMed ID: 6739224 [Abstract] [Full Text] [Related]
20. Design of more potent antagonists of the antidiuretic responses to arginine-vasopressin. Manning M, Olma A, Klis WA, Kolodziejczyk AM, Seto J, Sawyer WH. J Med Chem; 1982 Jan 15; 25(1):45-50. PubMed ID: 7086821 [Abstract] [Full Text] [Related] Page: [Next] [New Search]